Om Prakesh Yadava and Marc Ruel discuss minimally invasive cardiac surgery and the MIST trial, which is the first randomized controlled trial comparing a minimally invasive approach with sternotomy for coronary artery disease.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Coronary Disease - Surgery
May 29, 2018
May 24, 2018
Rune Haaverstad of Bergen University Hospital in Norway discusses transit-time flowmetry in CABG.
May 9, 2018
Shroyer and colleagues evaluated observed-to-expected outcome ratios for 30-day operative mortality and major morbidity across over 540,000 nonemergent first-time coronary artery bypass graft (CABG) procedures in The Society for Thoracic Surgeons Adult Cardiac Surgery Database.
May 2, 2018
Filmed at the 2017 EACTS Annual Meeting in Vienna, Austria, Stan Antonides moderates a discussion with David Taggart, Joseph Sabik, and Michael Mack on improving the patency and longevity of vein grafts.
May 1, 2018
The authors performed a patient-level meta-analysis of six randomized trials comparing left internal mammary artery (LIMA) + saphenous vein graft (SVG) versus LIMA + radial artery graft.
In Global News: Improving Vein Grafts, a Suture-Based Percutaneous Mitral Device, and Donating CT Surgical Equipment
April 27, 2018
Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial
April 24, 2018
The authors report on a randomized, multicenter, open-label, clinical trial involving 500 patients with 1460 saphenous vein grafts (SVG) who were assigned to three groups: (1) ticagrelor + asprin (ASA), (2) ticagrelor alone, or (3) ASA alone. Neither patients nor physicians were blinded to the allocation. The primary outcome was SVG patency at one
Hybrid Coronary Revascularization in Selected Patients With Multivessel Disease: 5-Year Clinical Outcomes of the Prospective Randomized Pilot Study
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR). Notably, the patients undergoing HCR had a LIMA to LAD via a minimally invasive appr
April 18, 2018
Coronary artery bypass grafting (CABG), the second most common cardiac procedure in the US, was added to the US Hospital Readmissions Reduction Program in 2015. Given the relatively high rate of readmission after CABG, Zywot and colleagues sought to develop a scale for predicting readmission risk.
April 13, 2018
Patient Care Michael Mack and Alec Vahanian discuss the state and future of transcatheter mitral valve replacement.